Pre-order Enquiry
Request Free Sample
Global Ibuprofen Market Insights and Forecast to 2028
SKU ID : QYR-19875853 | Publishing Date : 07-Jan-2022 | No. of pages : 93
Request Sample
Request Customization
Check Discounts
Ibuprofen is an API which is used to produce ibuprofen drugs. Finished drugs ibuprofen is a nonsteroidal anti-inflammatory drug (NSAID) derivative of propionic acid used for relieving pain, helping with fever and reducing inflammation.
Market Analysis and Insights: Global Ibuprofen Market
Due to the COVID-19 pandemic, the global Ibuprofen market size is estimated to be worth US$ 96 million in 2022 and is forecast to a readjusted size of US$ 112.3 million by 2028 with a CAGR of 2.7% during the review period. Fully considering the economic change by this health crisis, USP accounting for % of the Ibuprofen global market in 2021, is projected to value US$ million by 2028, growing at a revised % CAGR in the post-COVID-19 period. While Tablet segment is altered to an % CAGR throughout this forecast period.
Market competition is intense. Xinhua Pharmaceutical, IOLCP, Granules Biocause, Shasun, BASF and SI Group are the leaders of in the industry, with about 81% market shares.
China is the largest supplier of Ibuprofen, with a production market share nearly 48%. India is the second largest supplier of Ibuprofen, enjoying production market share nearly 30%.
North America is the largest sales place, with a sales market share nearly 29%. Following North America, Europe is the second largest sales place with the sales market share of 26%.
The classification of Ibuprofen includes USP and EP and the sales proportion of USP Ibuprofen is about 65%.
Ibuprofen is applied in Tablet, Capsule, Suspension and Other. The most proportion of Ibuprofen is used in Tablet, and the market share is about 46%.
Global Ibuprofen Scope and Segment
Ibuprofen market is segmented by Type and by Application. Players, stakeholders, and other participants in the global Ibuprofen market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by Type and by Application for the period 2017-2028.
Segment by Type
USP
EP
Segment by Application
Tablet
Capsule
Suspension
Others
By Company
Xinhua Pharmaceutical
IOLCP
Granules Biocause
Strides Shasun
BASF
SI Group
Xinhua-Perrigo Pharmaceutical
Hisoar
By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
U.A.E
Market Analysis and Insights: Global Ibuprofen Market
Due to the COVID-19 pandemic, the global Ibuprofen market size is estimated to be worth US$ 96 million in 2022 and is forecast to a readjusted size of US$ 112.3 million by 2028 with a CAGR of 2.7% during the review period. Fully considering the economic change by this health crisis, USP accounting for % of the Ibuprofen global market in 2021, is projected to value US$ million by 2028, growing at a revised % CAGR in the post-COVID-19 period. While Tablet segment is altered to an % CAGR throughout this forecast period.
Market competition is intense. Xinhua Pharmaceutical, IOLCP, Granules Biocause, Shasun, BASF and SI Group are the leaders of in the industry, with about 81% market shares.
China is the largest supplier of Ibuprofen, with a production market share nearly 48%. India is the second largest supplier of Ibuprofen, enjoying production market share nearly 30%.
North America is the largest sales place, with a sales market share nearly 29%. Following North America, Europe is the second largest sales place with the sales market share of 26%.
The classification of Ibuprofen includes USP and EP and the sales proportion of USP Ibuprofen is about 65%.
Ibuprofen is applied in Tablet, Capsule, Suspension and Other. The most proportion of Ibuprofen is used in Tablet, and the market share is about 46%.
Global Ibuprofen Scope and Segment
Ibuprofen market is segmented by Type and by Application. Players, stakeholders, and other participants in the global Ibuprofen market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by Type and by Application for the period 2017-2028.
Segment by Type
USP
EP
Segment by Application
Tablet
Capsule
Suspension
Others
By Company
Xinhua Pharmaceutical
IOLCP
Granules Biocause
Strides Shasun
BASF
SI Group
Xinhua-Perrigo Pharmaceutical
Hisoar
By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
U.A.E
Frequently Asked Questions
This market study covers the global and regional market with an in-depth analysis of the overall growth prospects in the market. Furthermore, it sheds light on the comprehensive competitive landscape of the global market. The report further offers a dashboard overview of leading companies encompassing their successful marketing strategies, market contribution, recent developments in both historic and present contexts.
- By product type
- By End User/Applications
- By Technology
- By Region
The report provides a detailed evaluation of the market by highlighting information on different aspects which include drivers, restraints, opportunities, and threats. This information can help stakeholders to make appropriate decisions before investing.
